Skip To Main Content
Vedin Barve on Muck Rack

Vedin Barve

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Vedin

Contact Vedin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Lurbinectedin in treating CNS metastases from small cell neuroendocrine prostate cancer—a case report

|
By William Kelly, Andrew Brenner, Avani Gunuganti, Vedin Barve, Vijay Gunuganti
| Frontiers
Abstract Background: De novo neuroendocrine prostate cancer is an aggressive, androgen receptor-independent subtype of prostate cancer with poor prognosis. Central nervous system (CNS) metastases from de novo neuroendocrine prostate tumors are rare, and evidence guiding treatment is limited. Lurbinectedin, approved for small cell lung cancer (SCLC), has shown activity in neuroendocrine tumors, though CNS-specific data remain sparse.
Open in Who Shared Issue with article?
See all 1 articles